IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Iranian Journal of Blood and Cancer

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.39

h-Index

2022-2023

 8

Rank

2022-2023

 23814

SJR

2022-2023

 0.125

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Iranian Journal of Blood and Cancer
Abbreviation Iran. J. Blood Cancer
Publication Type Journal
Subject Area, Categories, Scope Hematology (Q4); Oncology (Q4)
h-index 8
Overall Rank/Ranking 23814
SCImago Journal Rank (SJR) 0.125
Impact Score 0.39
Publisher Iranian Pediatric Hematology and Oncology Society
Country Iran
ISSN 20084609, 20084595
Best Quartile Q4
Coverage History 2014-2022




About Iranian Journal of Blood and Cancer


Iranian Journal of Blood and Cancer is a journal covering the technologies/fields/categories related to Hematology (Q4); Oncology (Q4). It is published by Iranian Pediatric Hematology and Oncology Society. The overall rank of Iranian Journal of Blood and Cancer is 23814. According to SCImago Journal Rank (SJR), this journal is ranked 0.125. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 8. The best quartile for this journal is Q4.

The ISSN of Iranian Journal of Blood and Cancer journal is 20084609, 20084595. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Iranian Journal of Blood and Cancer is cited by a total of 35 articles during the last 3 years (Preceding 2022).


Iranian Journal of Blood and Cancer Impact IF 2022-2023


The Impact IF 2022 of Iranian Journal of Blood and Cancer is 0.39, which is computed in 2023 as per its definition. Iranian Journal of Blood and Cancer IF is decreased by a factor of 0.04 and approximate percentage change is -9.3% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Iranian Journal of Blood and Cancer Impact IF 2023 Prediction


Impact IF 2022 of Iranian Journal of Blood and Cancer is 0.39. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Iranian Journal of Blood and Cancer. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.39
2021 0.43
2020 0.19
2019 0.21
2018 0.14
2017 0.22
2016 0.33
2015 0.20
2014 0.00

Iranian Journal of Blood and Cancer h-index


  Table Setting

Iranian Journal of Blood and Cancer has an h-index of 8. It means 8 articles of this journal have more than 8 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Iranian Journal of Blood and Cancer ISSN


The ISSN of Iranian Journal of Blood and Cancer is 20084609, 20084595. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Iranian Journal of Blood and Cancer Rank and SCImago Journal Rank (SJR)


The overall rank of Iranian Journal of Blood and Cancer is 23814. According to SCImago Journal Rank (SJR), this journal is ranked 0.125. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Iranian Journal of Blood and Cancer by Year


Year SJR
2023/2024 Coming Soon
2022 0.125
2021 0.138
2020 0.127
2019 0.141
2018 0.142
2017 0.131
2016 0.138
2015 0.133
2014

Ranking of Iranian Journal of Blood and Cancer by Year


Year Ranking
2023/2024 Coming Soon
2022 23814
2021 21906
2020 25748
2019 22454
2018 22166
2017 23198
2016 22571
2015 22787
2014 32108

Iranian Journal of Blood and Cancer Publisher


Table Setting

Iranian Journal of Blood and Cancer is published by Iranian Pediatric Hematology and Oncology Society. It's publishing house is located in Iran. Coverage history of this journal is as following: 2014-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Iranian Journal of Blood and Cancer is Iran. J. Blood Cancer. This abbreviation ('Iran. J. Blood Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Iranian Journal of Blood and Cancer


If your research field is/are related to Hematology (Q4); Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Iranian Journal of Blood and Cancer?

Iranian Journal of Blood and Cancer latest impact IF is 0.39. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.43 (2021) and 0.00 (2014), respectively, in the last 9 years. Moreover, its average IS is 0.23 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Iranian Journal of Blood and Cancer?

The Iranian Journal of Blood and Cancer has an SJR (SCImago Journal Rank) of 0.125, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.142 in 2018 and the lowest being in 2014. Furthermore, the average SJR of the Iranian Journal of Blood and Cancer over the previous 9-year period stands at 0.23.


What's the latest h-index of the Iranian Journal of Blood and Cancer?

The latest h-index of the Iranian Journal of Blood and Cancer is 8.


Who's the publisher of the Iranian Journal of Blood and Cancer?

The Iranian Journal of Blood and Cancer is published by the Iranian Pediatric Hematology and Oncology Society, with its country of publication being the Iran.


What's the current ranking of the Iranian Journal of Blood and Cancer?

The Iranian Journal of Blood and Cancer is currently ranked 23814 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 21906 in 2021 and its lowest position of 32108 in 2014.


What's the abbreviation or short name for the Iranian Journal of Blood and Cancer?

The standard ISO4 abbreviation for the Iranian Journal of Blood and Cancer is Iran. J. Blood Cancer.


Is the "Iranian Journal of Blood and Cancer" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Iranian Journal of Blood and Cancer is classified as a journal that the Iranian Pediatric Hematology and Oncology Society publishes.


What's the scope or major areas of the Iranian Journal of Blood and Cancer?

The Iranian Journal of Blood and Cancer encompasses the following areas:

  • Hematology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Iranian Journal of Blood and Cancer?

The Iranian Journal of Blood and Cancer is assigned the following International Standard Serial Numbers (ISSN): 20084609, 20084595.


What's the best quartile of the Iranian Journal of Blood and Cancer?

The best quartile for the Iranian Journal of Blood and Cancer is Q4 (2022).


What's the coverage history of the Iranian Journal of Blood and Cancer?

The Iranian Journal of Blood and Cancer coverage history can be summarized as follows: 2014-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Dermatologia Kliniczna journal 25442 Cornetis 7 0.00
Zeitschrift fur Germanistische Linguistik journal 22945 De Gruyter Mouton 15 0.19
European Union Politics journal 2250 SAGE Publications Ltd 72 2.64
Historia journal 27560 Universidade Estadual Paulista 7 0.02
Current Sociology journal 6591 SAGE Publications Ltd 76 2.29
Milan Journal of Mathematics journal 3120 Birkhauser Verlag Basel 28 1.79
Journal of Business Finance and Accounting journal 3221 Wiley-Blackwell Publishing Ltd 84 3.68
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
European Journal of Education journal 6079 Wiley-Blackwell Publishing Ltd 53 2.31
Libyan Studies journal 16122 Cambridge University Press 8 0.45

Check complete list




Year wise Impact Score (IS) of Iranian Journal of Blood and Cancer

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.39
2021 0.43
2020 0.19
2019 0.21
2018 0.14
2017 0.22
2016 0.33
2015 0.20
2014 0.00



Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All